drugset / Press release

Material Information - Argentina ANMAT has Approved the Marketing Authorization Application of BESREMi (Ropeginterferon alfa-2b) for PV

2025-06-18 · PharmaEssentia · original pharmaessentia.com ↗

Download Material Information - Argentina ANMAT has Approved the Marketing Authorization Application of BESREMi (Ropeginterferon alfa-2b) for PV Previous Next

The release as fetched from its publisher. pharmaessentia.com ↗